Andreas Georg Wibmer MD, Presenter: Nothing to Disclose

Irene Andrea Burger, Abstract Co-Author: Nothing to Disclose

Hebert Alberto Vargas MD, Abstract Co-Author: Nothing to Disclose

Molecular imaging of prostate cancer goes beyond the detection, localization and staging of the cancer but must also be capable of non-invasively providing insights into tumor biology. This information can be used to better understand the nature of prostate cancer, to support treatment decisions, and estimate the prognosis of patients. In this educational exhibit, we give an overview of the molecular imaging methods that are presently applied or are under clinical evaluation. We also refer to emerging techniques that are currently in the state of preclinical development (Figure 1).

RADIONUCLIDE IMAGING IMAGING OF CELL METABOLISM               Glucose, Choline, Acetate, Amino Acids (Leucine, Methionine, Trytophan), Nucleosides RECEPTORS AND MEMBRANE PROTEINS               Androgen receptor, Gastrin Releasing Peptide Receptor, PSMA, Others BONE MATRIX REPORTER GENE IMAGING MOLECULAR MAGNETIC RESONANCE IMAGING

http://abstract.rsna.org/uploads/2014/14015164/14015164_95fe.pdf

Wibmer, A, Burger, I, Vargas, H, Molecular Imaging of Prostate Cancer.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14015164.html